Anonymized buyer profiles from Steve's Goods CBG accounts. Real order specs, lead times, and reorder patterns. No embellishment — just what the accounts actually ordered and what worked.
Started with a single stock SKU in the nootropic section. Committed shelf placement and a one-page staff script drove sell-through fast enough that two locations were near-zero at six weeks. First reorder moved them to Growth tier pricing.
Read case study →Added CBG as a deliberate brand extension alongside an existing nootropic line. Custom 1:2 ratio positioned CBG as the lead compound. Bundled second-SKU reorder reached Growth tier equivalent pricing.
Read case study →Working through your own CBG evaluation? The resource guides cover margin math, shelf strategy, dosing tiers, and formulation ratios.
All case studies are representative buyer profiles — anonymized for confidentiality. Operational details are typical for accounts at the described volume tier. These statements have not been evaluated by the FDA. Our products are not intended to diagnose, treat, cure, or prevent any disease.